Sussman NM - Search Results

1

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM; 6002-US-005 Study Group. LeWitt PA, et al. Among authors: sussman nm. Ann Neurol. 2008 Mar;63(3):295-302. doi: 10.1002/ana.21315. Ann Neurol. 2008. PMID: 18306243 Clinical Trial.

2

A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease.

Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, Sussman NM. Stacy M, et al. Among authors: sussman nm. Neurology. 2008 Jun 3;70(23):2233-40. doi: 10.1212/01.wnl.0000313834.22171.17. Neurology. 2008. PMID: 18519872 Clinical Trial.

3

Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial.

Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM; 6002-US-051 Study Group. Fernandez HH, et al. Among authors: sussman nm. Parkinsonism Relat Disord. 2010 Jan;16(1):16-20. doi: 10.1016/j.parkreldis.2009.06.008. Epub 2009 Jul 19. Parkinsonism Relat Disord. 2010. PMID: 19616987 Clinical Trial.

4

A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson's disease, and atorvastatin.

Rao N, Dvorchik B, Sussman N, Wang H, Yamamoto K, Mori A, Uchimura T, Chaikin P. Rao N, et al. J Clin Pharmacol. 2008 Sep;48(9):1092-8. doi: 10.1177/0091270008320924. Epub 2008 Jun 13. J Clin Pharmacol. 2008. PMID: 18552277 Clinical Trial.

5

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.

Hauser RA, Shulman LM, Trugman JM, Roberts JW, Mori A, Ballerini R, Sussman NM; Istradefylline 6002-US-013 Study Group. Hauser RA, et al. Among authors: sussman nm. Mov Disord. 2008 Nov 15;23(15):2177-85. doi: 10.1002/mds.22095. Mov Disord. 2008. PMID: 18831530 Clinical Trial.

6

A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.

Factor S, Mark MH, Watts R, Struck L, Mori A, Ballerini R, Sussman NM; Istradefylline 6002-US-007 Study Group. Factor S, et al. Among authors: sussman nm. Parkinsonism Relat Disord. 2010 Jul;16(6):423-6. doi: 10.1016/j.parkreldis.2010.02.014. Epub 2010 Mar 24. Parkinsonism Relat Disord. 2010. PMID: 20338800 Clinical Trial. No abstract available.

7

Postmarketing studies.

Sussman NM. Sussman NM. Adv Neurol. 1998;76:263-6. Adv Neurol. 1998. PMID: 9408485 Review. No abstract available.

8

Effectiveness and tolerability of istradefylline for the treatment of restless legs syndrome: an exploratory study in five female patients.

Decerce J, Smith LF, Gonzalez W, Sussman NM. Decerce J, et al. Among authors: sussman nm. Curr Ther Res Clin Exp. 2007 Sep;68(5):349-59. doi: 10.1016/j.curtheres.2007.11.001. Curr Ther Res Clin Exp. 2007. PMID: 24692766 Free PMC article.

9

Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial.

Cramer J, Vachon L, Desforges C, Sussman NM. Cramer J, et al. Among authors: sussman nm. Epilepsia. 1995 Nov;36(11):1111-7. doi: 10.1111/j.1528-1157.1995.tb00469.x. Epilepsia. 1995. PMID: 7588455 Clinical Trial.

10

European investigational antiepilepsy drug trials.

Sussman NM. Sussman NM. Epilepsy Res Suppl. 1993;10:149-55. Epilepsy Res Suppl. 1993. PMID: 8251090 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page